Other Titles

Nurse Practitioner-Based Education Impact on Patients’ Weight Loss Medication Decisions & Compliance: A Research Proposal [Poster Title]

Abstract

Obesity has become more of a problem in the world that is leading to further health issues. Research shows that worldwide obesity has contributed to over a million deaths every year. Obesity leads to increased risks of diabetes, cardiovascular problems, and many others. Medications such as glucagon-like peptide-1 receptor agonists (GLP1-RAs) are now available for weight management in an injectable and oral form. There are risks and benefits to both the injectable and oral forms that patients may not be aware of when deciding the best option for them.

With the craze surrounding the use of these weight loss medications, many obese patients are making spontaneous decisions to use the medications without being aware of the potential risks and side effects. Side effects, such as nausea, vomiting, constipation, hair loss, and fatigue can be difficult to tolerate and can lead to non-compliance with therapy. This presentation gives an overview of the importance of patient education related to the use of weight loss medications in an effort to support compliance and symptom management to improve patient outcomes.

Notes

References:

Oshman, L., Othman, A., Furst, W., Heisler, M., Kraftson, A., Zouani, Y., Hershey, C., Cho, T. -C., Guetterman, T., Piatt, G., & Griauzde, D. H. (2023). Primary care providers’ perceived barriers to obesity treatment and opportunities for improvement: A mixed methods study. PLoS ONE, 17(4), 1-15. https://doi.org/10.1371/journal.pone.0284474

Popoviciu, M. -S., Paduraru, L., Yahya, G., Metwally, K., & Cavalu, S. (2023). Emerging role of GLP-1 agonists in obesity: A comprehensive review of randomized controlled trials. International Journal of Molecular Sciences, 24(13), 10449. https://doi.org/10.3390/ijms241310449

Description

This poster presentation gives an overview of the importance of patient education related to the use of weight loss medications in an effort to support compliance and symptom management to improve patient outcomes.

Author Details

Hannah Ledger, BSN; Teresa Teasley, DNP; Michelle Dykes, EdD

Sigma Membership

Theta Tau

Type

Poster

Format Type

Text-based Document

Study Design/Type

Literature Review

Research Approach

N/A

Keywords:

Primary Care, Teaching and Learning Strategies, Clinical Practice, Health Promotion and Disease Prevention, Obesity, Patient Education, Weight Loss Medications, Patient Outcomes

Conference Name

48th Biennial Convention

Conference Host

Sigma Theta Tau International

Conference Location

Indianapolis, Indiana, USA

Conference Year

2025

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record. All permission requests should be directed accordingly and not to the Sigma Repository. All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

Abstract Review Only: Reviewed by Event Host

Acquisition

Proxy-submission

Date of Issue

2025-11-19

Click on the above link to access the poster.

Share

COinS
 

The Importance of Educating Patients on Side Effects of Weight Loss Medications

Indianapolis, Indiana, USA

Obesity has become more of a problem in the world that is leading to further health issues. Research shows that worldwide obesity has contributed to over a million deaths every year. Obesity leads to increased risks of diabetes, cardiovascular problems, and many others. Medications such as glucagon-like peptide-1 receptor agonists (GLP1-RAs) are now available for weight management in an injectable and oral form. There are risks and benefits to both the injectable and oral forms that patients may not be aware of when deciding the best option for them.

With the craze surrounding the use of these weight loss medications, many obese patients are making spontaneous decisions to use the medications without being aware of the potential risks and side effects. Side effects, such as nausea, vomiting, constipation, hair loss, and fatigue can be difficult to tolerate and can lead to non-compliance with therapy. This presentation gives an overview of the importance of patient education related to the use of weight loss medications in an effort to support compliance and symptom management to improve patient outcomes.